Agenda

5 min   

Welcome and Introductions

45 min 

  • BRCA and Beyond – Clinical Focus on the DNA Damage Response Pathway
  • Advancing Therapeutic Paradigms – Examining the Role of PARP Inhibitors in Ovarian Cancer
  • Translating Tumor Sequencing into Clinical Decision Making – Practical Strategies for the Oncology Clinician
  • Integrating PARP Inhibitors into Practice – Expert Answers to Top Clinical Questions

10 min

Wrap-Up and Q&A